Hilde Windels
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Ms. Hilde Windels is an Independent Director at PHAXIAM Therapeutics SA, a Chief Executive Officer & Director at Antelope Dx BV, a Chairman at Celyad Oncology SA, an Independent Non-Executive Director at MDxHealth SA, an Executive Chairman & Co-Chief Executive Officer at MyCartis NV and an Independent Director at Gimv NV.
She is on the Board of Directors at PHAXIAM Therapeutics SA, Antelope Dx BV, MDxHealth SA, Windels Hilde BV, Microphyt SA and Gimv NV.
Ms. Windels was previously employed as an Independent Director by Ablynx NV, an Independent Director by ERYTech Pharma SA, an Executive Director by Biocartis Group NV, a Chief Executive Officer by Biocartis SA, a Chief Financial Officer & Director by deVGen NV, a Manager by ING Bank NV, Amsterdam, succursale de Lancy/Genève, a Chief Financial Officer by SEPS Pharma NV, and a Chief Financial Officer by TiGenix NV.
She also served on the board at Vlaams Instituut voor Biotechnologie - Flanders Institute and FlandersBio vzw.
She received her graduate degree from Katholieke Universiteit Leuven.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MDXHEALTH S.A. -.--% | 01/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MDXHEALTH SA | Directeur/Membre du Conseil | 01/11/2017 |
| CELYAD ONCOLOGY SA | Président | 23/06/2022 |
| GIMV NV | Directeur/Membre du Conseil | - |
| PHAXIAM THERAPEUTICS S.A. | Directeur/Membre du Conseil | 23/06/2023 |
Microphyt SA
Microphyt SA BiotechnologyHealth Technology Researches, develops, produces and markets natural bioactive products from microalgae | Directeur/Membre du Conseil | - |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Develops a point-of-need diagnostics platform that allows patients, consumers and healthcare professionals to have on-the-spot access to key health parameters | Fondateur | 01/01/2019 |
Windels Hilde BV | Directeur/Membre du Conseil | 01/01/2001 |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology Develops technologies for healthcare personalization needs | Directeur Général | 01/01/2015 |
| Sociétés | Poste | Fin |
|---|---|---|
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/06/2019 |
| ░░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 19 |
|---|---|
TiGenix NV
TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
MDxHealth SA
MDxHealth SA Medical SpecialtiesHealth Technology Develops and commercializes epigenetic tests & services for cancer assessment | Health Technology |
Gimv NV
Gimv NV Investment ManagersFinance Acts as a private equity and venture capital firm | Finance |
ING Bank NV, Amsterdam, succursale de Lancy/Genève
ING Bank NV, Amsterdam, succursale de Lancy/Genève Regional BanksFinance Provides commercial banking services | Finance |
deVGen NV
deVGen NV BiotechnologyHealth Technology Provides biotechnology services for the pharmaceutical and agrochemical industries | Health Technology |
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology Develops technologies for healthcare personalization needs | Health Technology |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Health Technology |
Celyad Oncology SA
Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
SEPS Pharma NV
SEPS Pharma NV Pharmaceuticals: GenericHealth Technology Provides controlled drug delivery and develops self emulsifying prodrug systems | Health Technology |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit networking organization for the life sciences and biotechnology | Commercial Services |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
Microphyt SA
Microphyt SA BiotechnologyHealth Technology Researches, develops, produces and markets natural bioactive products from microalgae | Health Technology |
Biocartis Group NV
Biocartis Group NV Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
Windels Hilde BV | |
Antelope Dx BV
Antelope Dx BV Packaged SoftwareTechnology Services Develops a point-of-need diagnostics platform that allows patients, consumers and healthcare professionals to have on-the-spot access to key health parameters | Technology Services |
PHAXIAM Therapeutics SA
PHAXIAM Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops red blood cell-based therapeutics for severe forms of cancer & orphan diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national